HBK Investments’s Wave Life Sciences WVE Stock Holding History

HBK Investments’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-12,509	Closed	-$486K	–	1076
2019 Q1	$486K	Buy	+12,509	New	+$508K	﹤0.01%	830

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

HBK Investments's WVE Position: Q2 2019 in Review

HBK Investments sold out of Wave Life Sciences (WVE) in Q2 2019, closing a stake of 12,509 shares — an estimated $486K sold.

HBK Investments first reported a position in WVE in Q1 2019 and held it in 1 quarter. The position peaked at $486K in Q1 2019. 100 funds tracked by Wall St. Rank hold WVE as of Q2 2019.

HBK Investments reported no remaining Wave Life Sciences position as of Q2 2019 after selling out during the quarter.
HBK Investments sold 12,509 Wave Life Sciences shares in Q2 2019, an estimated $486K.
HBK Investments first reported a position in Wave Life Sciences in Q1 2019 and held it in 1 quarter.
HBK Investments's Wave Life Sciences position peaked at $486K in Q1 2019.
100 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.